Cargando…

Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates

[Image: see text] APOBEC3B (A3B) deamination activity on ssDNA is considered a contributing factor to tumor heterogeneity and drug resistance in a number of human cancers. Despite its clinical impact, little is known about A3B ssDNA substrate preference. We have used nuclear magnetic resonance to mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Manjuan, Mallinger, Aurélie, Tortorici, Marcello, Newbatt, Yvette, Richards, Meirion, Mirza, Amin, van Montfort, Rob L. M., Burke, Rosemary, Blagg, Julian, Kaserer, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430498/
https://www.ncbi.nlm.nih.gov/pubmed/30130388
http://dx.doi.org/10.1021/acschembio.8b00639
Descripción
Sumario:[Image: see text] APOBEC3B (A3B) deamination activity on ssDNA is considered a contributing factor to tumor heterogeneity and drug resistance in a number of human cancers. Despite its clinical impact, little is known about A3B ssDNA substrate preference. We have used nuclear magnetic resonance to monitor the catalytic turnover of A3B substrates in real-time. This study reports preferred nucleotide sequences for A3B substrates, including optimized 4-mer oligonucleotides, and reveals a breadth of substrate recognition that includes DNA sequences known to be mutated in drug-resistant cancer clones. Our results are consistent with available clinical and structural data and may inform the design of substrate-based A3B inhibitors.